Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions? (English)
- New search for: Friedman, D. J.
- New search for: Granger, C. B.
- New search for: Friedman, D. J.
- New search for: Granger, C. B.
In:
EUROPEAN HEART JOURNAL
;
39
, 32
;
2956-2958
;
2018
-
ISSN:
- Article (Journal) / Print
-
Title:Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?
-
Contributors:Friedman, D. J. ( author ) / Granger, C. B. ( author )
-
Published in:EUROPEAN HEART JOURNAL ; 39, 32 ; 2956-2958
-
Publisher:
- New search for: Oxford University Press
-
Publication date:2018-01-01
-
Size:3 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.12
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.12 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 39, Issue 32
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2915
-
Atrial fibrillation and stroke: anticoagulation in trials and real-world settingsLüscher, T. F. et al. | 2018
- 2919
-
From basic science to high performance medicineEschenhagen, T. et al. | 2018
- 2922
-
From Bench to Bedside| 2018
- 2923
-
The German Cardiac SocietySchipke, J. D. / Arnold, G. et al. | 2018
- 2927
-
Building a Bridge between Physicians and PatientsWichert, M. et al. | 2018
- 2931
-
ZORAKeller, S. et al. | 2018
- 2932
-
Stroke prevention in atrial fibrillation: re-defining ‘real-world data’ within the broader data universeFanaroff, A. C. / Steffel, J. / Alexander, J. H. / Lip, G. Y. / Califf, R. M. / Lopes, R. D. et al. | 2018
- 2942
-
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablationKirchhof, P. / Haeusler, K. G. / Blank, B. / De Bono, J. / Callans, D. / Elvan, A. / Fetsch, T. / Van Gelder, I. C. / Gentlesk, P. / Grimaldi, M. et al. | 2018
- 2956
-
Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?Friedman, D. J. / Granger, C. B. et al. | 2018
- 2959
-
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trialEzekowitz, M. D. / Pollack, C. V. / Halperin, J. L. / England, R. D. / VanPelt Nguyen, S. / Spahr, J. / Sudworth, M. / Cater, N. B. / Breazna, A. / Oldgren, J. et al. | 2018
- 2972
-
Initiating anticoagulation with the intention of cardioverting: does drug choice matter?Mahaffey, K. W. / Turakhia, M. P. et al. | 2018
- 2975
-
A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulationCowan, J. C. / Wu, J. / Hall, M. / Orlowski, A. / West, R. M. / Gale, C. P. et al. | 2018
- 2984
-
Major progress in anticoagulant uptake for atrial fibrillation at last: does it translate into stroke prevention?Freedman, B. et al. | 2018
- 2997
-
The RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapyPavlovic, D. / Kirchhof, P. / Fabritz, L. et al. | 2018
- 3001
-
A rare cause of pericardial effusion due to intracardiac cement embolismSwojanowsky, P. / Brinkmeier-Theofanopoulou, M. / Schmitt, C. / Mehlhorn, U. et al. | 2018